Triumvira Immunologics
PrivateLast Round
Series A
Extension
Mar 17, 2022
Total Funding Raised
$100M
Momentum Score
25 /100
Company Overview
Triumvira is a biotechnology company specializing in the development of immunotherapy-based drugs that offer innovative T-cell therapies for cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Triumvira Immunologics Comps
Public and private peers based on sector, stage, and business model.
Triumvira Immunologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 17, 2022 | ||||
| Series A | Aug 27, 2020 |
Key People
Founding team and executive leadership
Triumvira Immunologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| B Capital Group | Series A Extension |
| Oceanpine Capital | Series A |
| Northpond Ventures | Series A |
| Myeloma Investment Fund | Series A Extension |
| Bloom Burton & Co. | Series A, Series A Extension |
| Viva Biotech | Series A |
| Northpond Ventures | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2025
Will present updated clinical data at the 2025 SITC Spring Scientific Conference.
- Jan 23, 2025
Presented abstract at the 2025 ASCO Gastrointestinal Cancers Symposium.
Triumvira Immunologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Triumvira Immunologics's valuation, stock price, and market status.
